FDA Drug Application (021859) for HYLENEX RECOMBINANT by HALOZYME THERAP

Back to FDA Applications sponsored by HALOZYME THERAP

Application Number021859
Product Number001
FormINJECTABLE;INJECTION
Dosage150 UNITS/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameHYLENEX RECOMBINANT
Active IngredientHYALURONIDASE RECOMBINANT HUMAN



Back to FDA Applications sponsored by HALOZYME THERAP

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.